Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Canadian (TSX) Biotech Industry Analysis

UpdatedJun 18, 2025
DataAggregated Company Financials
Companies26
  • 7D1.4%
  • 3M-9.7%
  • 1Y15.2%
  • YTDn/a

Over the last 7 days, the Biotech industry has risen 1.4%, driven by gains from Oncolytics Biotech of 56%. In the last 12 months, the industry was up 15%. In the next few years, earnings are forecast to decline by 11% annually.

Industry Valuation and Performance

Has the Canadian Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 18 Jun 2025CA$1.5bCA$90.6m-CA$285,721,470.7822.1x-5.2x16.3x
Fri, 16 May 2025CA$1.8bCA$94.1m-CA$315,443,899.2622.7x-5.6x18.7x
Sun, 13 Apr 2025CA$1.4bCA$92.1m-CA$285,841,273.7719.8x-4.7x14.7x
Tue, 11 Mar 2025CA$1.6bCA$88.7m-CA$325,007,445.7820.6x-4.8x17.5x
Thu, 06 Feb 2025CA$1.6bCA$87.5m-CA$318,893,184.7225.1x-5x18.3x
Sat, 04 Jan 2025CA$1.5bCA$85.6m-CA$323,047,850.8816x-4.6x17.5x
Mon, 02 Dec 2024CA$1.5bCA$83.4m-CA$310,404,122.748.1x-4.8x18x
Wed, 30 Oct 2024CA$1.4bCA$80.4m-CA$282,244,093.378.7x-5x17.7x
Fri, 27 Sep 2024CA$975.6mCA$80.2m-CA$268,323,039.724.8x-3.6x12.2x
Sun, 25 Aug 2024CA$978.6mCA$80.2m-CA$284,326,995.839.5x-3.4x12.2x
Tue, 23 Jul 2024CA$1.1bCA$76.1m-CA$339,964,477.7911.1x-3.2x14.2x
Thu, 20 Jun 2024CA$1.1bCA$76.8m-CA$339,985,305.4011.1x-3.3x14.6x
Sat, 18 May 2024CA$1.1bCA$77.1m-CA$367,554,030.9411.2x-3.1x14.8x
Mon, 15 Apr 2024CA$925.0mCA$79.5m-CA$301,900,009.3013.1x-3.1x11.6x
Wed, 13 Mar 2024CA$1.1bCA$91.6m-CA$319,822,627.7611x-3.4x11.9x
Fri, 09 Feb 2024CA$1.0bCA$87.2m-CA$323,603,166.2210x-3.2x11.8x
Sun, 07 Jan 2024CA$3.6bCA$86.2m-CA$515,871,225.006.9x-7x42x
Tue, 05 Dec 2023CA$3.8bCA$86.1m-CA$542,676,059.005.4x-6.9x43.6x
Thu, 02 Nov 2023CA$3.7bCA$89.1m-CA$538,529,706.007.7x-6.9x41.8x
Sat, 30 Sep 2023CA$3.9bCA$88.8m-CA$530,758,412.006x-7.3x43.7x
Mon, 28 Aug 2023CA$4.0bCA$87.4m-CA$510,271,494.006.4x-7.8x45.5x
Wed, 26 Jul 2023CA$4.0bCA$81.5m-CA$515,987,753.0013.6x-7.8x49.6x
Fri, 23 Jun 2023CA$4.0bCA$86.4m-CA$541,957,527.0013.1x-7.3x45.8x
Sun, 21 May 2023CA$3.8bCA$82.8m-CA$608,966,275.0011.4x-6.2x45.4x
Tue, 18 Apr 2023CA$2.4bCA$83.7m-CA$595,579,537.0012.8x-4.1x29x
Thu, 16 Mar 2023CA$2.6bCA$90.6m-CA$587,559,913.008.1x-4.5x29x
Sat, 11 Feb 2023CA$3.0bCA$89.0m-CA$587,856,761.008.4x-5.1x33.5x
Mon, 09 Jan 2023CA$3.0bCA$87.5m-CA$526,225,652.0011.7x-5.7x34x
Wed, 07 Dec 2022CA$3.3bCA$88.6m-CA$579,892,466.007.1x-5.7x37x
Fri, 04 Nov 2022CA$3.1bCA$86.1m-CA$570,554,197.0013x-5.4x35.6x
Sun, 02 Oct 2022CA$3.3bCA$86.1m-CA$550,520,366.0013.5x-6.1x38.7x
Tue, 30 Aug 2022CA$3.5bCA$81.6m-CA$535,448,590.0013.9x-6.5x42.6x
Thu, 28 Jul 2022CA$3.2bCA$87.3m-CA$564,237,342.0011.3x-5.7x36.8x
Sat, 25 Jun 2022CA$3.1bCA$181.5m-CA$607,227,399.0012.5x-5x16.9x
Price to Earnings Ratio

-5x


Total Market Cap: CA$3.1bTotal Earnings: -CA$607,227,399.00Total Revenue: CA$181.5mTotal Market Cap vs Earnings and Revenue0%0%0%
Canadian Biotech Industry Price to Earnings3Y Average -5.3x202320242025
Current Industry PE
  • Investors are pessimistic on the Canadian Biotechnology industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 28.2x is higher than the industry's current PS ratio of 16.3x.
Past Earnings Growth
  • The earnings for companies in the Biotechnology industry have improved over the last three years.
  • Meanwhile revenues for these companies have declined 21% per year.
  • This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.

Industry Comparison

How does Canadian Biotech compare with similar industries?

CA Market0.41%
Healthcare-1.43%
Biotech1.38%
Biotech1.38%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ONC Oncolytics BiotechCA$1.0132.9%
+CA$22.2m		-27.3%PB13.8x
EPRX Eupraxia PharmaceuticalsCA$5.849.4%
+CA$17.9m		68.3%PE-5.6x
RKV Rakovina TherapeuticsCA$0.055-8.3%
CA$3.2m		-47.6%PB4.9x
COV Covalon TechnologiesCA$2.402.1%
+CA$1.4m		11.1%PE17.8x
MPH MedicureCA$1.169.4%
+CA$1.0m		6.4%PS0.6x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

HEM

CA$0.13

Hemostemix

7D

-16.7%

1Y

127.3%

BCT

CA$4.26

BriaCell Therapeutics

7D

-12.0%

1Y

-85.8%

ONCO

CA$1.42

Onco-Innovations

7D

-4.7%

1Y

n/a

EPRX

CA$5.84

Eupraxia Pharmaceuticals

7D

9.4%

1Y

68.3%

METX

CA$10.00

ME Therapeutics Holdings

7D

-2.5%

1Y

150.0%

TTI

CA$0.78

Thiogenesis Therapeutics

7D

1.3%

1Y

11.4%

ONC

CA$1.01

Oncolytics Biotech

7D

32.9%

1Y

-27.3%

RKV

CA$0.055

Rakovina Therapeutics

7D

-8.3%

1Y

-47.6%

TELO

CA$0.08

Telo Genomics

7D

6.7%

1Y

-60.0%

COV

CA$2.40

Covalon Technologies

7D

2.1%

1Y

11.1%

MRVL

CA$0.12

Marvel Biosciences

7D

21.1%

1Y

4.5%

MSCL

CA$0.55

Satellos Bioscience

7D

-6.8%

1Y

0%

Here's Why We're Watching Satellos Bioscience's (TSE:MSCL) Cash Burn Situation

May 25
Here's Why We're Watching Satellos Bioscience's (TSE:MSCL) Cash Burn Situation

DTC

CA$0.73

Defence Therapeutics

7D

-7.6%

1Y

-18.0%

MPH

CA$1.16

Medicure

7D

9.4%

1Y

6.4%

This Is Why Shareholders May Want To Hold Back On A Pay Rise For Medicure Inc.'s (CVE:MPH) CEO

May 14
This Is Why Shareholders May Want To Hold Back On A Pay Rise For Medicure Inc.'s (CVE:MPH) CEO

EDT

CA$0.84

Spectral Medical

7D

-3.4%

1Y

68.0%

TH

CA$3.41

Theratechnologies

7D

-2.8%

1Y

88.4%